These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 24040120)
21. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4. Zhao G; Wang B; Liu Y; Zhang JG; Deng SC; Qin Q; Tian K; Li X; Zhu S; Niu Y; Gong Q; Wang CY Mol Cancer Ther; 2013 Nov; 12(11):2569-80. PubMed ID: 24013097 [TBL] [Abstract][Full Text] [Related]
22. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis. Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of DCLK1 down-regulates PD-L1 expression through Hippo pathway in human pancreatic cancer. Yan R; Li J; Zhou Y; Yao L; Sun R; Xu Y; Ge Y; An G Life Sci; 2020 Jan; 241():117150. PubMed ID: 31837335 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition. Wang C; Yin W; Liu H J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845 [TBL] [Abstract][Full Text] [Related]
25. MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG. An N; Zheng B Technol Cancer Res Treat; 2020; 19():1533033819898729. PubMed ID: 32301392 [TBL] [Abstract][Full Text] [Related]
26. miRNA-193b-5p Suppresses Pancreatic Cancer Cell Proliferation, Invasion, Epithelial Mesenchymal Transition, and Tumor Growth by Inhibiting eEF2K. Gurbuz N; Kahraman N; Sonmez HE; Mokhlis HA; Kosar PA; Ozpolat B Anticancer Agents Med Chem; 2022; 22(14):2607-2618. PubMed ID: 35718922 [TBL] [Abstract][Full Text] [Related]
27. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1. Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682 [TBL] [Abstract][Full Text] [Related]
28. Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells. Kawamura D; Takemoto Y; Nishimoto A; Ueno K; Hosoyama T; Shirasawa B; Tanaka T; Kugimiya N; Harada E; Hamano K Oncol Rep; 2017 Nov; 38(5):3238-3244. PubMed ID: 29048622 [TBL] [Abstract][Full Text] [Related]
30. Induction of let-7e gene expression attenuates oncogenic phenotype in HCT-116 colorectal cancer cells through targeting of DCLK1 regulation. Khodadadi Kohlan A; Saidijam M; Amini R; Samadi P; Najafi R Life Sci; 2019 Jul; 228():221-227. PubMed ID: 31075231 [TBL] [Abstract][Full Text] [Related]
31. miR-613 inhibits the growth and invasiveness of human hepatocellular carcinoma via targeting DCLK1. Wang W; Zhang H; Wang L; Zhang S; Tang M Biochem Biophys Res Commun; 2016 May; 473(4):987-992. PubMed ID: 27049311 [TBL] [Abstract][Full Text] [Related]
32. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition. Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3. Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446 [TBL] [Abstract][Full Text] [Related]
34. MiR-424 suppressed viability and invasion by targeting to the DCLK1 in neuroblastoma. Wan MF; Yang N; Qu NY; Pan YY; Shan YQ; Li P Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5526-5533. PubMed ID: 32495887 [TBL] [Abstract][Full Text] [Related]
35. Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis. Ito H; Tanaka S; Akiyama Y; Shimada S; Adikrisna R; Matsumura S; Aihara A; Mitsunori Y; Ban D; Ochiai T; Kudo A; Arii S; Yamaoka S; Tanabe M PLoS One; 2016; 11(1):e0146564. PubMed ID: 26764906 [TBL] [Abstract][Full Text] [Related]
36. DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent manner. Razi S; Sadeghi A; Asadi-Lari Z; Tam KJ; Kalantari E; Madjd Z Clin Exp Med; 2021 Feb; 21(1):139-147. PubMed ID: 32965580 [TBL] [Abstract][Full Text] [Related]
37. MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma. Hu J; Li L; Chen H; Zhang G; Liu H; Kong R; Chen H; Wang Y; Li Y; Tian F; Lv X; Li G; Sun B Cell Death Dis; 2018 Jul; 9(8):807. PubMed ID: 30042387 [TBL] [Abstract][Full Text] [Related]
38. hsa_circRNA_001587 upregulates SLC4A4 expression to inhibit migration, invasion, and angiogenesis of pancreatic cancer cells via binding to microRNA-223. Zhang X; Tan P; Zhuang Y; Du L Am J Physiol Gastrointest Liver Physiol; 2020 Dec; 319(6):G703-G717. PubMed ID: 32878470 [TBL] [Abstract][Full Text] [Related]
39. DCLK1 plays an important role in colorectal cancer tumorgenesis through the regulation of miR-200c. Mohammadi Y; Tavangar SM; Saidijam M; Amini R; Etemadi K; Karimi Dermani F; Najafi R Biomed Pharmacother; 2018 Jul; 103():301-307. PubMed ID: 29656186 [TBL] [Abstract][Full Text] [Related]
40. miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer. Wang J; Wang S; Zhou J; Qian Q Biomed Pharmacother; 2018 Jun; 102():147-152. PubMed ID: 29550638 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]